美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Abivax S.A.

81.99

+0.96001.18%

盤後：81.990.00000.00%18:55 EDT

成交量：59.25萬

成交額：4,816.46萬

市值：61.62億

市盈率：-25.79

高：82.51

開：80.01

低：80.01

收：81.03

52周最高：82.51

52周最低：4.77

股本：7,515.13萬

流通股本：3,877.21萬

量比：0.57

換手率：1.53%

股息：- -

股息率：- -

每股收益(TTM):-3.1785

每股收益(LYR):-2.8941

淨資產收益率：-196.12%

總資產收益率：-48.60%

市淨率：-803.99

市盈率(LYR):-28.33

資料載入中...

總覽公司新聞公告

Abivax8月11日成交額為4068.67萬美元

Abivax8月8日成交額為4682.88萬美元

Abivax8月6日成交額為1.15億美元

Abivax8月4日成交額為3745.79萬美元

Abivax8月1日成交額為8991.02萬美元

Abivax盤中異動快速上漲5.06%

Abivax7月30日成交額為9777.64萬美元

I-Mab逆勢翻盤

阿基米德Biotech

Abivax7月28日成交額為1.15億美元

Abivax盤中異動臨近午盤股價大跌5.05%

Abivax盤中異動早盤股價大漲5.75%報72.55美元

盤前 | 特斯拉績後跌近6%，谷歌績後漲近4%，名創優品漲近6%，海外市場增長收入28%

老虎资讯综合

異動解讀 | 重磅新藥臨牀試驗成功，Abivax盤前大漲5.54%

異動解讀 | Abivax股價盤前再漲5.54%，新藥臨牀試驗利好持續發酵

盤前異動 | 特斯拉績後盤前跌近6%，Q2營收、淨利潤雙位數下滑

老虎资讯综合

一夜暴漲465%！FIC藥物炸出新時代→

新藥數據驚豔，美股Abivax暴漲586%，能否打破"燒錢魔咒"？

腾讯自选股

異動解讀 | 突破性研究結果公佈，Abivax股價夜盤暴漲5.67%

Abivax飆升至580%，其口服新藥 Obefazimod 在潰瘍性結腸炎 III 期誘導試驗中取得積極結果

老虎资讯综合

異動解讀 | 重大突破！Abivax新藥臨牀試驗成功，股價盤中暴漲547%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ABVX/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ABVX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABVX\",,,,,undefined,":{"symbol":"ABVX","market":"US","secType":"STK","nameCN":"Abivax S.A.","latestPrice":81.99,"timestamp":1756843200000,"preClose":81.03,"halted":0,"volume":592455,"hourTrading":{"tag":"盘后","latestPrice":81.99,"preClose":81.99,"latestTime":"18:55 EDT","volume":25635,"amount":2103164.0593,"timestamp":1756853756822},"delay":0,"floatShares":38772100,"shares":75151300,"eps":-3.17854,"marketStatus":"未開盤","change":0.96,"latestTime":"09-02 16:00:00 EDT","open":80.01,"high":82.51,"low":80.01,"amount":48164642.32305,"amplitude":0.030853,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.17854,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1756886400000},"marketStatusCode":0,"adr":0,"adrRate":1,"listingDate":1697774400000,"exchange":"NASDAQ","adjPreClose":81.03,"preHourTrading":{"tag":"盘前","latestPrice":79.95,"preClose":81.03,"latestTime":"09:28 EDT","volume":6106,"amount":488755.9912,"timestamp":1756819680037},"postHourTrading":{"tag":"盘后","latestPrice":81.99,"preClose":81.99,"latestTime":"18:55 EDT","volume":25635,"amount":2103164.0593,"timestamp":1756853756822},"volumeRatio":0.569731},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABVX\",,,,,undefined,":{"symbol":"ABVX","floatShares":38772100,"roa":"-48.60%","roe":"-196.12%","lyrEps":-2.894125,"volumeRatio":0.569731,"shares":75151300,"dividePrice":0,"high":82.51,"amplitude":0.030853,"preClose":81.03,"low":80.01,"week52Low":4.77,"pbRate":"-803.99","psRate":"500.56","week52High":82.51,"institutionHeld":0,"latestPrice":81.99,"eps":-3.17854,"divideRate":0,"volume":592455,"delay":0,"ttmEps":-3.17854,"open":80.01,"prevYearClose":7.32,"prevWeekClose":81.03,"prevMonthClose":81.03,"prevQuarterClose":7.65,"fiveDayClose":77.46,"twentyDayClose":72.07,"sixtyDayClose":8.15,"earningDate":1757260800000,"earningTime":"盘后"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ABVX\",params:#limit:5,,,undefined,":[{"date":"2025-09-08","symbol":"ABVX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1757361600000,"name":null,"time":"盤後","dateTimestamp":1757304000000,"actualEps":null},{"market":"US","date":"2025-06-02","symbol":"ABVX","fiscalQuarterEnding":"2025/03","expectedEps":-0.76,"name":null,"time":"盤後","type":"earning","dateTimestamp":1748836800000,"reportTimeType":"post","actualEps":-0.87},{"date":"2025-03-24","symbol":"ABVX","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/12","expectedEps":-0.67,"defaultRemindTime":1742803200000,"name":null,"time":"盤前","dateTimestamp":1742788800000,"actualEps":null},{"market":"US","date":"2024-11-14","symbol":"ABVX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":null},{"date":"2024-09-09","symbol":"ABVX","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1725868800000,"name":null,"time":"盤前","dateTimestamp":1725854400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ABVX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ABVX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.5714,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":7,"updateTime":1753329600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ABVX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ABVX","date":"2025-08-29","current":-27.951762,"percent":0.002268,"low":-27.992449,"twenty":-6.982711,"median":-4.432115,"eighty":-2.275271,"high":-0.02231,"avg":-5.75133,"sd":5.432596,"marketCap":6054693876.38},"quantilePoints":[{"date":"2023-10-27","current":-7.823172,"twenty":-7.328793,"median":-6.587224,"eighty":-5.845656,"marketCap":753894810.45},{"date":"2023-11-03","current":-6.291292,"twenty":-6.250217,"median":-6.06538,"eighty":-6.010614,"marketCap":611163613.59},{"date":"2023-11-10","current":-6.503512,"twenty":-6.645905,"median":-6.346058,"eighty":-6.06538,"marketCap":637532258.17},{"date":"2023-11-17","current":-7.092251,"twenty":-6.941614,"median":-6.503512,"eighty":-6.069488,"marketCap":704987904.63},{"date":"2023-11-24","current":-6.558278,"twenty":-6.982681,"median":-6.613045,"eighty":-6.085918,"marketCap":654468961.83},{"date":"2023-12-01","current":-6.469283,"twenty":-6.777344,"median":-6.486397,"eighty":-6.085918,"marketCap":645658268.08},{"date":"2023-12-08","current":-6.667811,"twenty":-6.729423,"median":-6.558278,"eighty":-6.270755,"marketCap":658292574.17},{"date":"2023-12-15","current":-6.708886,"twenty":-6.708886,"median":-6.565124,"eighty":-6.291292,"marketCap":675019398.57},{"date":"2023-12-22","current":-6.859493,"twenty":-6.749961,"median":-6.585661,"eighty":-6.304984,"marketCap":690021158.62},{"date":"2023-12-29","current":-6.722577,"twenty":-6.78282,"median":-6.609622,"eighty":-6.321414,"marketCap":681416772.26},{"date":"2024-01-05","current":-6.626736,"twenty":-6.777344,"median":-6.626736,"eighty":-6.346059,"marketCap":664561787.4},{"date":"2024-01-12","current":-6.845802,"twenty":-6.796512,"median":-6.667811,"eighty":-6.407671,"marketCap":685854313.55},{"date":"2024-01-19","current":-7.023793,"twenty":-6.859493,"median":-6.681503,"eighty":-6.435054,"marketCap":698334715.34},{"date":"2024-01-26","current":-7.986412,"twenty":-6.982718,"median":-6.681503,"eighty":-6.435054,"marketCap":792063074.67},{"date":"2024-02-02","current":-8.137618,"twenty":-7.092251,"median":-6.715732,"eighty":-6.469283,"marketCap":807847078.54},{"date":"2024-02-09","current":-7.972666,"twenty":-7.379774,"median":-6.743115,"eighty":-6.503512,"marketCap":785337680.3},{"date":"2024-02-16","current":-7.738985,"twenty":-7.738985,"median":-6.763653,"eighty":-6.503512,"marketCap":761909093.06},{"date":"2024-02-23","current":-8.385046,"twenty":-7.788813,"median":-6.78419,"eighty":-6.508989,"marketCap":829978945.38},{"date":"2024-03-01","current":-8.879901,"twenty":-7.848771,"median":-6.818419,"eighty":-6.548694,"marketCap":878391233.38},{"date":"2024-03-08","current":-8.921139,"twenty":-7.986412,"median":-6.859493,"eighty":-6.569232,"marketCap":892211380.33},{"date":"2024-03-15","current":-8.659965,"twenty":-8.228342,"median":-6.982681,"eighty":-6.577447,"marketCap":863166780.31},{"date":"2024-03-22","current":-9.319772,"twenty":-8.319065,"median":-7.010102,"eighty":-6.584292,"marketCap":926107447.06},{"date":"2024-03-28","current":-9.209804,"twenty":-8.585737,"median":-7.078559,"eighty":-6.597984,"marketCap":910336135.23},{"date":"2024-04-05","current":-9.732151,"twenty":-8.736943,"median":-7.311316,"eighty":-6.610307,"marketCap":967400801.65},{"date":"2024-04-12","current":-5.879845,"twenty":-8.706701,"median":-7.078559,"eighty":-6.566493,"marketCap":928230894.29},{"date":"2024-04-19","current":-6.030284,"twenty":-8.692955,"median":-6.99641,"eighty":-6.48982,"marketCap":950004364.47},{"date":"2024-04-26","current":-6.311356,"twenty":-8.670962,"median":-6.941624,"eighty":-6.433272,"marketCap":998864220.67},{"date":"2024-05-03","current":-5.987697,"twenty":-8.585737,"median":-6.859493,"eighty":-6.311356,"marketCap":946423801.22},{"date":"2024-05-10","current":-5.698107,"twenty":-8.470271,"median":-6.80815,"eighty":-6.289097,"marketCap":907055615.77},{"date":"2024-05-17","current":-5.502208,"twenty":-8.401541,"median":-6.777344,"eighty":-6.21545,"marketCap":883582818.48},{"date":"2024-05-24","current":-5.348896,"twenty":-8.33556,"median":-6.749961,"eighty":-6.06538,"marketCap":855336978.03},{"date":"2024-05-31","current":-5.357413,"twenty":-8.297072,"median":-6.736269,"eighty":-6.030284,"marketCap":858278233.57},{"date":"2024-06-07","current":-5.493691,"twenty":-8.288824,"median":-6.708886,"eighty":-5.988933,"marketCap":883175015.23},{"date":"2024-06-14","current":-5.042271,"twenty":-8.277827,"median":-6.681503,"eighty":-5.938296,"marketCap":801878490.85},{"date":"2024-06-21","current":-5.510725,"twenty":-8.253084,"median":-6.681503,"eighty":-5.777439,"marketCap":872433075.44},{"date":"2024-06-28","current":-4.974132,"twenty":-8.244837,"median":-6.681503,"eighty":-5.74004,"marketCap":786723361.52},{"date":"2024-07-05","current":-5.306309,"twenty":-8.203599,"median":-6.667811,"eighty":-5.629968,"marketCap":847517911.35},{"date":"2024-07-12","current":-5.408517,"twenty":-8.118374,"median":-6.619891,"eighty":-5.595899,"marketCap":868631706.71},{"date":"2024-07-15","current":-5.417034,"twenty":-8.099129,"median":-6.613045,"eighty":-5.590788,"marketCap":873513053.92},{"date":"2024-08-02","current":-4.676203,"twenty":-8.079885,"median":-6.609622,"eighty":-5.583974,"marketCap":745105907.03},{"date":"2024-08-09","current":-4.513478,"twenty":-8.008406,"median":-6.578816,"eighty":-5.515836,"marketCap":727494223.22},{"date":"2024-08-16","current":-4.316495,"twenty":-7.986412,"median":-6.534318,"eighty":-5.490284,"marketCap":700482151.8},{"date":"2024-08-23","current":-4.453526,"twenty":-7.978164,"median":-6.503512,"eighty":-5.44429,"marketCap":730827498.61},{"date":"2024-08-30","current":-4.898879,"twenty":-7.906686,"median":-6.449861,"eighty":-5.413627,"marketCap":801684090.61},{"date":"2024-09-06","current":-4.667638,"twenty":-7.862699,"median":-6.432827,"eighty":-5.36082,"marketCap":764519824.83},{"date":"2024-09-13","current":-3.822511,"twenty":-7.855735,"median":-6.332367,"eighty":-5.335268,"marketCap":748409890.75},{"date":"2024-09-20","current":-3.623827,"twenty":-7.841256,"median":-6.30817,"eighty":-5.285867,"marketCap":716147844.73},{"date":"2024-09-27","current":-3.630961,"twenty":-7.835207,"median":-6.291292,"eighty":-5.156403,"marketCap":720043812.45},{"date":"2024-10-04","current":-3.210083,"twenty":-7.830393,"median":-6.281546,"eighty":-4.898879,"marketCap":627325694.46},{"date":"2024-10-11","current":-2.96041,"twenty":-7.805992,"median":-6.132492,"eighty":-4.671064,"marketCap":573856377.14},{"date":"2024-10-18","current":-3.434789,"twenty":-7.774725,"median":-6.075649,"eighty":-4.6094,"marketCap":659899758.53},{"date":"2024-10-25","current":-3.324219,"twenty":-7.75548,"median":-6.033455,"eighty":-4.49121,"marketCap":637070240.87},{"date":"2024-10-31","current":-3.438356,"twenty":-7.738985,"median":-6.030284,"eighty":-4.463804,"marketCap":662378132.46},{"date":"2024-11-08","current":-3.427655,"twenty":-7.738985,"median":-5.993854,"eighty":-4.429546,"marketCap":655972131.38},{"date":"2024-11-15","current":-3.106647,"twenty":-7.711493,"median":-5.970662,"eighty":-4.328485,"marketCap":583153684.93},{"date":"2024-11-22","current":-3.010345,"twenty":-7.590528,"median":-5.940851,"eighty":-3.765459,"marketCap":560275247.04},{"date":"2024-11-29","current":-2.837956,"twenty":-7.546541,"median":-5.882667,"eighty":-3.688029,"marketCap":531199944.09},{"date":"2024-12-06","current":-2.848666,"twenty":-7.379774,"median":-5.732176,"eighty":-3.623827,"marketCap":534218918.72},{"date":"2024-12-13","current":-2.548806,"twenty":-7.311316,"median":-5.65552,"eighty":-3.566759,"marketCap":474325506.61},{"date":"2024-12-20","current":-2.520248,"twenty":-7.311316,"median":-5.604416,"eighty":-3.452623,"marketCap":464239022.01},{"date":"2024-12-27","current":-2.516678,"twenty":-7.267503,"median":-5.595899,"eighty":-3.437643,"marketCap":465029850.03},{"date":"2025-01-03","current":-2.49883,"twenty":-7.157971,"median":-5.578864,"eighty":-3.421948,"marketCap":454676281.41},{"date":"2025-01-10","current":-2.309632,"twenty":-7.081298,"median":-5.52776,"eighty":-3.400548,"marketCap":421851498.87},{"date":"2025-01-17","current":-2.156736,"twenty":-7.048438,"median":-5.506467,"eighty":-3.355607,"marketCap":393925230.6},{"date":"2025-01-24","current":-2.178161,"twenty":-7.018316,"median":-5.493691,"eighty":-3.318513,"marketCap":402353167.1},{"date":"2025-01-31","current":-2.156736,"twenty":-6.993672,"median":-5.459621,"eighty":-3.135894,"marketCap":398893952.88},{"date":"2025-02-07","current":-2.038902,"twenty":-6.982711,"median":-5.442586,"eighty":-3.053859,"marketCap":375339390.95},{"date":"2025-02-14","current":-2.431685,"twenty":-6.966258,"median":-5.417034,"eighty":-3.014625,"marketCap":450591803.66},{"date":"2025-02-21","current":-2.725249,"twenty":-6.900568,"median":-5.408517,"eighty":-2.924742,"marketCap":505993414.61},{"date":"2025-02-28","current":-2.478798,"twenty":-6.859493,"median":-5.361671,"eighty":-2.877224,"marketCap":457649034.34},{"date":"2025-03-07","current":-2.62524,"twenty":-6.859493,"median":-5.348896,"eighty":-2.848666,"marketCap":504421902.75},{"date":"2025-03-14","current":-1.950178,"twenty":-6.845802,"median":-5.331861,"eighty":-2.792772,"marketCap":375893933.73},{"date":"2025-03-21","current":-2.425222,"twenty":-6.818419,"median":-5.306309,"eighty":-2.725249,"marketCap":466899893.66},{"date":"2025-03-28","current":-2.16502,"twenty":-6.797881,"median":-5.23817,"eighty":-2.643099,"marketCap":411881933.29},{"date":"2025-04-04","current":-1.798189,"twenty":-6.791035,"median":-5.118927,"eighty":-2.598783,"marketCap":350804145.45},{"date":"2025-04-11","current":-1.7874,"twenty":-6.777344,"median":-4.936505,"eighty":-2.541667,"marketCap":352326323.68},{"date":"2025-04-17","current":-1.884502,"twenty":-6.777344,"median":-4.813235,"eighty":-2.527388,"marketCap":377676205.37},{"date":"2025-04-25","current":-2.187427,"twenty":-6.755438,"median":-4.676203,"eighty":-2.49883,"marketCap":437738722.61},{"date":"2025-05-02","current":-2.334934,"twenty":-6.749961,"median":-4.641945,"eighty":-2.473083,"marketCap":464043181.1},{"date":"2025-05-09","current":-2.219807,"twenty":-6.744484,"median":-4.599123,"eighty":-2.430392,"marketCap":441113036.42},{"date":"2025-05-16","current":-1.936126,"twenty":-6.732161,"median":-4.504914,"eighty":-2.406016,"marketCap":381685399.33},{"date":"2025-05-23","current":-1.820966,"twenty":-6.723946,"median":-4.470655,"eighty":-2.350016,"marketCap":362101694.69},{"date":"2025-05-30","current":-1.900139,"twenty":-6.714362,"median":-4.462091,"eighty":-2.329767,"marketCap":380507035.56},{"date":"2025-06-06","current":-2.513168,"twenty":-6.708886,"median":-4.444961,"eighty":-2.329767,"marketCap":534533766.17},{"date":"2025-06-13","current":-1.97798,"twenty":-6.692456,"median":-4.410704,"eighty":-2.276706,"marketCap":425231303.24},{"date":"2025-06-20","current":-1.793505,"twenty":-6.681503,"median":-4.342188,"eighty":-2.264946,"marketCap":382035064.22},{"date":"2025-06-27","current":-2.138541,"twenty":-6.681503,"median":-4.299366,"eighty":-2.248589,"marketCap":464697383.01},{"date":"2025-07-03","current":-2.289493,"twenty":-6.681503,"median":-3.786854,"eighty":-2.248786,"marketCap":500190485.77},{"date":"2025-07-11","current":-2.429597,"twenty":-6.678765,"median":-3.702296,"eighty":-2.250599,"marketCap":527449091.87},{"date":"2025-07-18","current":-2.945587,"twenty":-6.667811,"median":-3.641661,"eighty":-2.25491,"marketCap":634057320.66},{"date":"2025-07-25","current":-23.061864,"twenty":-6.681503,"median":-3.652361,"eighty":-2.257399,"marketCap":5041932651.84},{"date":"2025-08-01","current":-24.891124,"twenty":-6.708886,"median":-3.72013,"eighty":-2.264403,"marketCap":5288723102.26},{"date":"2025-08-08","current":-24.565749,"twenty":-6.748592,"median":-3.822511,"eighty":-2.266806,"marketCap":5307007573.85},{"date":"2025-08-15","current":-24.412019,"twenty":-6.788297,"median":-4.320777,"eighty":-2.26785,"marketCap":5283013491.79},{"date":"2025-08-22","current":-27.056654,"twenty":-6.856755,"median":-4.350753,"eighty":-2.269596,"marketCap":5836300408.78},{"date":"2025-08-29","current":-27.951762,"twenty":-6.982711,"median":-4.432115,"eighty":-2.275271,"marketCap":6054693876.38}],"updateTime":1756873007704},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ABVX\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2558691278","title":"Abivax8月11日成交額為4068.67萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558691278","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558691278?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 09:15","pubTimestamp":1754961321,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日，Abivax成交额为4068.67万美元，成交额较昨日减少13.12%，当日成交量为58.40万股。Abivax于2025年8月11日跌1.61%，报69.0美元，该股过去5个交易日跌4.26%，年初至今涨842.62%，过去60日涨1031.15%。公司正在 3 期临床试验中评估其候选药物 obefazimod 用于治疗成人中度至重度活动性溃疡性结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812091536a6e08032&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812091536a6e08032&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABVX","BK4139"],"gpt_icon":1},{"id":"2558503872","title":"Abivax8月8日成交額為4682.88萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558503872","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558503872?lang=zh_tw&edition=fundamental","pubTime":"2025-08-09 09:15","pubTimestamp":1754702123,"startTime":"0","endTime":"0","summary":"美东时间2025年8月8日，Abivax成交额为4682.88万美元，成交额较昨日减少42.14%，当日成交量为66.84万股。Abivax于2025年8月8日涨0.16%，报70.13美元，该股过去5个交易日跌2.53%，年初至今涨858.06%，过去60日涨1061.09%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-08|4682.88万|-42.14%|66.84万|#|2025-08-07|8093.06万|-29.39%|114.54万|#|2025-08-06|1.15亿|76.53%|163.60万|#|2025-08-05|6492.88万|73.34%|92.65万|#|2025-08-04|3745.79万|-58.34%|52.68万|Abivax SA 是一家总部位于法国的临床阶段生物技术公司，专注于开发利用身体自然调节机制来稳定慢性炎症性疾病患者免疫反应的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809091537a6dbdc49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809091537a6dbdc49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABVX"],"gpt_icon":0},{"id":"2557458974","title":"Abivax8月6日成交額為1.15億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557458974","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557458974?lang=zh_tw&edition=fundamental","pubTime":"2025-08-07 09:15","pubTimestamp":1754529325,"startTime":"0","endTime":"0","summary":"美东时间2025年8月6日，Abivax成交额为1.15亿美元，成交额较昨日增加76.53%，当日成交量为163.60万股。Abivax于2025年8月6日跌2.57%，报69.09美元，该股过去5个交易日跌2.47%，年初至今涨843.85%，过去60日涨929.66%。公司正在 3 期临床试验中评估其候选药物 obefazimod 用于治疗成人中度至重度活动性溃疡性结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807091537a6d78cf4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807091537a6d78cf4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABVX","BK4139"],"gpt_icon":0},{"id":"2557358046","title":"Abivax8月4日成交額為3745.79萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557358046","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557358046?lang=zh_tw&edition=fundamental","pubTime":"2025-08-05 09:15","pubTimestamp":1754356524,"startTime":"0","endTime":"0","summary":"美东时间2025年8月4日，Abivax成交额为3745.79万美元，成交额较昨日减少58.34%，当日成交量为52.68万股。Abivax于2025年8月4日涨0.17%，报72.07美元，该股过去5个交易日涨8.26%，年初至今涨884.56%，过去60日涨987.03%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-04|3745.79万|-58.34%|52.68万|#|2025-08-01|8991.02万|-15.91%|125.29万|#|2025-07-31|1.07亿|9.35%|146.53万|#|2025-07-30|9777.64万|-39.89%|137.95万|#|2025-07-29|1.63亿|40.97%|233.93万|Abivax SA 是一家总部位于法国的临床阶段生物技术公司，专注于开发利用身体自然调节机制来稳定慢性炎症性疾病患者免疫反应的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805091533a4756362&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805091533a4756362&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABVX"],"gpt_icon":0},{"id":"2556842827","title":"Abivax8月1日成交額為8991.02萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556842827","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556842827?lang=zh_tw&edition=fundamental","pubTime":"2025-08-02 09:15","pubTimestamp":1754097324,"startTime":"0","endTime":"0","summary":"美东时间2025年8月1日，Abivax成交额为8991.02万美元，成交额较昨日减少15.91%，当日成交量为125.29万股。Abivax于2025年8月1日涨0.24%，报71.95美元，该股过去5个交易日涨8.2%，年初至今涨882.86%，过去60日涨965.85%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-01|8991.02万|-15.91%|125.29万|#|2025-07-31|1.07亿|9.35%|146.53万|#|2025-07-30|9777.64万|-39.89%|137.95万|#|2025-07-29|1.63亿|40.97%|233.93万|#|2025-07-28|1.15亿|-51.49%|172.23万|Abivax SA 是一家总部位于法国的临床阶段生物技术公司，专注于开发利用身体自然调节机制来稳定慢性炎症性疾病患者免疫反应的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802091533a47095aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802091533a47095aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABVX","BK4139"],"gpt_icon":0},{"id":"2556327908","title":"Abivax盤中異動 快速上漲5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556327908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556327908?lang=zh_tw&edition=fundamental","pubTime":"2025-08-01 00:18","pubTimestamp":1753978696,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日00时18分，Abivax股票出现异动，股价大幅上涨5.06%。截至发稿，该股报74.42美元/股，成交量67.8585万股，换手率0.90%，振幅6.17%。Abivax股票所在的生物技术行业中，整体涨幅为2.87%。公司正在 3 期临床试验中评估其候选药物 obefazimod 用于治疗成人中度至重度活动性溃疡性结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801001816a46defc5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801001816a46defc5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABVX"],"gpt_icon":0},{"id":"2555079770","title":"Abivax7月30日成交額為9777.64萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555079770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555079770?lang=zh_tw&edition=fundamental","pubTime":"2025-07-31 09:15","pubTimestamp":1753924526,"startTime":"0","endTime":"0","summary":"美东时间2025年7月30日，Abivax成交额为9777.64万美元，成交额较昨日减少39.89%，当日成交量为137.95万股。Abivax于2025年7月30日涨1.48%，报70.84美元，该股过去5个交易日涨3.26%，年初至今涨867.69%，过去60日涨885.19%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-30|9777.64万|-39.89%|137.95万|#|2025-07-29|1.63亿|40.97%|233.93万|#|2025-07-28|1.15亿|-51.49%|172.23万|#|2025-07-25|2.38亿|-59.58%|354.05万|#|2025-07-24|5.89亿|-68.21%|833.98万|Abivax SA 是一家总部位于法国的临床阶段生物技术公司，专注于开发利用身体自然调节机制来稳定慢性炎症性疾病患者免疫反应的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731091539a46c6491&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731091539a46c6491&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABVX"],"gpt_icon":1},{"id":"2555169098","title":"I-Mab逆勢翻盤","url":"https://stock-news.laohu8.com/highlight/detail?id=2555169098","media":"阿基米德Biotech","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555169098?lang=zh_tw&edition=fundamental","pubTime":"2025-07-30 08:37","pubTimestamp":1753835826,"startTime":"0","endTime":"0","summary":"I-Mab今年以来上涨近150%，但4-1BB双抗的价值还远未释放，知名投行Jefferies对I-Mab给出5美元的目标价，仍有翻倍空间。维立志博拥有一项4-1BB双抗资产，而I-Mab拥有两项4-1BB双抗资产，并且全部在美国开展临床。I-Mab踩准大药方向。攻克毒性难题I-Mab两项4-1BB双抗具有低毒性，得益于精密的分子设计。其实，在天境生物中美业务切割时，康桥资本就已经预见到I-Mab将翻盘，而市场共识直到二代IO、4-1BB双抗价值显现时，才恍然大悟I-Mab翻盘了。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730090954a6c8a029&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730090954a6c8a029&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09887","IMAB","BK1583","ABVX","BK1574","BK1161","01952"],"gpt_icon":1},{"id":"2555088365","title":"Abivax7月28日成交額為1.15億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555088365","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555088365?lang=zh_tw&edition=fundamental","pubTime":"2025-07-29 09:15","pubTimestamp":1753751726,"startTime":"0","endTime":"0","summary":"美东时间2025年7月28日，Abivax成交额为1.15亿美元，成交额较昨日减少51.49%，当日成交量为172.23万股。Abivax于2025年7月28日涨0.12%，报66.57美元，该股过去5个交易日涨556.51%，年初至今涨809.43%，过去60日涨834.97%。公司正在 3 期临床试验中评估其候选药物 obefazimod 用于治疗成人中度至重度活动性溃疡性结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729091543a6c6bfed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729091543a6c6bfed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABVX"],"gpt_icon":1},{"id":"2554796581","title":"Abivax盤中異動 臨近午盤股價大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554796581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554796581?lang=zh_tw&edition=fundamental","pubTime":"2025-07-25 23:57","pubTimestamp":1753459049,"startTime":"0","endTime":"0","summary":"北京时间2025年07月25日23时57分，Abivax股票出现波动，股价大幅下挫5.05%。截至发稿，该股报66.24美元/股，成交量172.408万股，换手率2.72%，振幅5.75%。机构评级方面，在所有13家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Abivax股票所在的生物技术行业中，整体跌幅为0.78%。公司正在 3 期临床试验中评估其候选药物 obefazimod 用于治疗成人中度至重度活动性溃疡性结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072523572994baeb21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072523572994baeb21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABVX","BK4139"],"gpt_icon":1},{"id":"2553198785","title":"Abivax盤中異動 早盤股價大漲5.75%報72.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553198785","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553198785?lang=zh_tw&edition=fundamental","pubTime":"2025-07-24 21:34","pubTimestamp":1753364080,"startTime":"0","endTime":"0","summary":"北京时间2025年07月24日21时34分，Abivax股票出现异动，股价大幅拉升5.75%。截至发稿，该股报72.55美元/股，成交量167.911万股，换手率2.65%，振幅6.47%。Abivax股票所在的生物技术行业中，整体涨幅为0.18%。公司正在 3 期临床试验中评估其候选药物 obefazimod 用于治疗成人中度至重度活动性溃疡性结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724213440971c25e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724213440971c25e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABVX","BK4139"],"gpt_icon":1},{"id":"1133444199","title":"盤前 | 特斯拉績後跌近6%，谷歌績後漲近4%，名創優品漲近6%，海外市場增長收入28%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133444199","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133444199?lang=zh_tw&edition=fundamental","pubTime":"2025-07-24 20:03","pubTimestamp":1753358604,"startTime":"0","endTime":"0","summary":"$名创优品$盘前涨近6%，港股大涨7%，中国市场收入增长10%，海外市场增长收入28%。预计期内收入达48.5亿元人民币，同比增20%，其中中国市场收入增长10%，海外市场增长收入28%。谷歌绩后盘前上涨近4%，二季度营收同比增长14%至964.3亿美元，并创下历史纪录，每股收益同比增长22%至2.31美元，均超预期。$特斯拉$绩后盘前跌近6%，Q2营收、净利润双位数下滑。能源业务收入下跌7%。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3c94c29cbd6e48dd1763faf2a3863d59","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GOOG","MNSO","AAL","NOW","NDAQ","TMUS","OPEN","TSLA","STM","ABVX","DB"],"gpt_icon":1},{"id":"1156915810","title":"異動解讀 | 重磅新藥臨牀試驗成功，Abivax盤前大漲5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=1156915810","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156915810?lang=zh_tw&edition=fundamental","pubTime":"2025-07-24 16:30","pubTimestamp":1753345848,"startTime":"0","endTime":"0","summary":"周四盘前，法国生物科技公司Abivax S.A.股价大涨5.54%，延续了此前的强劲涨势。这一涨幅主要源于该公司近期公布的突破性临床试验结果。Abivax宣布，其用于治疗中度至重度活动性溃疡性结肠炎的候选药物obefazimod在两项关键性III期临床试验中均达到主要终点。试验结果显示，obefazimod在8周诱导期内，相较于安慰剂组显著提高了患者的临床缓解率。受此利好消息影响，Abivax股价在过去几个交易日内持续上涨。今日盘前的5.54%涨幅显示，市场对Abivax的发展前景仍保持乐观态度。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"dcc54a12bb9d1d1308c82fe12f0e51e6","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ABVX"],"gpt_icon":1},{"id":"1195846412","title":"異動解讀 | Abivax股價盤前再漲5.54%，新藥臨牀試驗利好持續發酵","url":"https://stock-news.laohu8.com/highlight/detail?id=1195846412","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195846412?lang=zh_tw&edition=fundamental","pubTime":"2025-07-24 16:30","pubTimestamp":1753345831,"startTime":"0","endTime":"0","summary":"法国生物技术公司Abivax股价在周四盘前继续攀升，涨幅达5.54%。这一涨势是对该公司此前公布的重大临床试验结果的持续反应。本周二，Abivax宣布其用于治疗溃疡性结肠炎的口服小分子药物obefazimod在两项关键性III期临床试验中达到主要终点。Abivax计划在2026年下半年向美国FDA提交新药申请。这一积极预期持续推动Abivax股价上涨，而今日盘前的涨幅反映了投资者对公司前景的持续看好。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"dcc54a12bb9d1d1308c82fe12f0e51e6","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ABVX"],"gpt_icon":1},{"id":"1125427368","title":"盤前異動 | 特斯拉績後盤前跌近6%，Q2營收、淨利潤雙位數下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=1125427368","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125427368?lang=zh_tw&edition=fundamental","pubTime":"2025-07-24 16:10","pubTimestamp":1753344600,"startTime":"0","endTime":"0","summary":"期内，软件收入增长约10%至73.9亿美元，毛利率为83.9%，略低于预期的84%。特斯拉绩后盘前跌近6%，Q2营收、净利润双位数下滑消息面上，在汽车销量持续下滑的情况下，特斯拉的净利润进一步下滑，第二季度净利润下跌16%至11.72亿美元。能源业务收入下跌7%。特斯拉表示，其营收和盈利能力的下降是由于销量下降和监管信用积分的减少。特斯拉表示，该公司已于6月开始生产首批平价车型，并预计今年下半年将实现量产。","market":"hk","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"6b21df534720d4af5cf1fe913b70ee7e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBM","TMUS","TSLA","ABVX"],"gpt_icon":0},{"id":"2553308274","title":"一夜暴漲465%！FIC藥物炸出新時代→","url":"https://stock-news.laohu8.com/highlight/detail?id=2553308274","media":"谈思生物","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553308274?lang=zh_tw&edition=fundamental","pubTime":"2025-07-24 15:00","pubTimestamp":1753340429,"startTime":"0","endTime":"0","summary":"受临床数据刺激，Abivax盘后股价瞬间飙涨465%，公司市值由6.34亿美元蹿升至约35.82亿美元。其次，是FIC优势。鉴于全新的作用途径，ABX464将为那些，其他机制药物治疗无效或不耐受的患者提供新的治疗选择。ABTECT研究是目前最大规模的UC三期临床试验之一，30个月内在36个国家600多个临床中心共1275名患者入组，并纳入了最大比例、对JAK抑制剂响应不足的患者。二是ABX464潜力巨大，除了UC，Abivax还相继为其开展了CD单药治疗以及UC联合治疗2大适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724151529a460b07b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724151529a460b07b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABVX","BK4139"],"gpt_icon":0},{"id":"2553522150","title":"新藥數據驚豔，美股Abivax暴漲586%，能否打破\"燒錢魔咒\"？","url":"https://stock-news.laohu8.com/highlight/detail?id=2553522150","media":"腾讯自选股","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553522150?lang=zh_tw&edition=fundamental","pubTime":"2025-07-24 08:37","pubTimestamp":1753317439,"startTime":"0","endTime":"0","summary":"美东时间7月23日，美股生物技术公司Abivax股价盘初一度暴涨超596%，最终收涨586%，最新市值43.48亿美元。消息面上，Abivax宣布，其首创新型口服miR-124增强剂Obefazimod在中度至重度溃疡性结肠炎的ABTECT 8周诱导试验中取得积极的III期结果。单押miRNA疗法2023年6月份，Abivax递交的obefazimod临床试验申请获CDE受理。不过，药物正式获批上市前，Abivaxs是否能凭借单一候选药物冲出重围仍未可知。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724082621971acd29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724082621971acd29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBD","ABVX","BK4139"],"gpt_icon":1},{"id":"1108137418","title":"異動解讀 | 突破性研究結果公佈，Abivax股價夜盤暴漲5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=1108137418","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108137418?lang=zh_tw&edition=fundamental","pubTime":"2025-07-24 08:02","pubTimestamp":1753315362,"startTime":"0","endTime":"0","summary":"7月23日夜盘，法国生物技术公司Abivax股价大涨5.67%，引发市场广泛关注。这一显著涨幅源于该公司公布了其核心药物obefazimod在治疗溃疡性结肠炎方面取得的突破性临床试验结果。根据Abivax发布的公告，obefazimod在针对中度至重度活动性溃疡性结肠炎的ABTECT III期临床试验中取得了积极成果。试验结果显示，在8周诱导期内，obefazimod在实现临床缓解方面明显优于安慰剂。这一突破性进展不仅为溃疡性结肠炎患者带来新的治疗希望，也大大提升了投资者对Abivax前景的信心。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ABVX"],"gpt_icon":1},{"id":"1128758434","title":"Abivax飆升至580%，其口服新藥 Obefazimod 在潰瘍性結腸炎 III 期誘導試驗中取得積極結果","url":"https://stock-news.laohu8.com/highlight/detail?id=1128758434","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128758434?lang=zh_tw&edition=fundamental","pubTime":"2025-07-23 22:07","pubTimestamp":1753279640,"startTime":"0","endTime":"0","summary":"7月23日（周三），美股盘中Abivax飙升至580%，其口服新药 Obefazimod 在溃疡性结肠炎 III 期诱导试验中取得积极结果，并计划向 FDA 提交申请。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"dcc54a12bb9d1d1308c82fe12f0e51e6","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"gpt_icon":0},{"id":"1123514331","title":"異動解讀 | 重大突破！Abivax新藥臨牀試驗成功，股價盤中暴漲547%","url":"https://stock-news.laohu8.com/highlight/detail?id=1123514331","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123514331?lang=zh_tw&edition=fundamental","pubTime":"2025-07-23 21:35","pubTimestamp":1753277750,"startTime":"0","endTime":"0","summary":"周三盘中，法国生物技术公司Abivax S.A.股价惊人暴涨547%，引发市场轰动。这一戏剧性涨幅背后，是该公司在溃疡性结肠炎治疗领域取得的重大突破。据悉，Abivax的口服溃疡性结肠炎新药obefazimod在两项大型三期临床试验中取得了积极结果。这一突破性进展不仅为溃疡性结肠炎患者带来新的治疗希望，也极大地提升了投资者对Abivax前景的信心。然而，随着obefazimod的成功，公司的融资能力有望大幅提升。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"dcc54a12bb9d1d1308c82fe12f0e51e6","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ABVX"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":63,"code":"91000000","status":"200"}]}}